Le Lézard
Classified in: Health, Business
Subjects: NPT, CXP

Well-Known Hematologist-Oncologist Leads Perlmutter Cancer Center's New Location In Sunset Park, Expanding Care To Brooklyn Residents


NEW YORK, Feb. 3, 2020 /PRNewswire/ -- Hematologist/oncologist Rami K. Daya, MD is well known to countless residents of Brooklyn, especially those he has treated for cancer throughout his long and distinguished career. Now, he has taken on a new responsibility, leading a team of renowned cancer experts at the NYU Langone Perlmutter Cancer Center's brand-new, multi-disciplinary ambulatory location in Sunset Park.

(PRNewsfoto/NYU School of Medicine)

With more than 30 years of clinical experience, Daya treats many types of cancer, but specializes in blood and gastrointestinal cancers, such as multiple myeloma and colorectal cancer. And as director of medical oncology at NYU Langone Hospital-Brooklyn, he oversees all cancer treatment at the hospital as well.

With breast cancer, colorectal cancer, and lung cancer on the rise in Brooklyn, the need for convenient, high-quality and coordinated care in the borough is constantly growing. Daya will lead efforts to develop new patient screening programs for early detection and prevention. Patients in Brooklyn will have access to the resources and technology of NYU's Perlmutter Cancer Center, one of only 50 cancer centers to receive comprehensive designation from the National Cancer Institute.

"This new, state-of-the-art facility offers the most advanced radiation oncology treatment, the latest in immunotherapy, chemotherapy and infusion therapy -- all within two blocks of the hospital for convenience," says Daya, who also serves as a clinical assistant professor of medicine at NYU Grossman School of Medicine and medical director of the Infusion Center at NYU Langone Hospital-Brooklyn. "The Sunset Park location allows us to treat our patients with the highest level of care and provide comprehensive services right here in Brooklyn."

Certified by the American Board of Internal Medicine in both medical oncology and hematology, Daya received his medical degree from Damascus University and completed his residency in internal medicine at New York Methodist Hospital. He then went on to complete fellowship training in hematology/oncology at University Hospital in Newark, NJ. He also has contributed to several research publications over his career, including Clinical & Translational Oncology, and Hem/Onc Today.

The new outpatient center in Sunset Park expands the capabilities of Perlmutter Cancer Center and doubles its capacity to treat patients in Brooklyn with the same level of care provided at its Manhattan location. Other services at the new center include blood transfusion, a pharmacy for preparing treatments on-site, pathology services, genetic counseling, nutrition and social services.

"Dr. Daya enjoys an excellent reputation in treating cancer, and is well known to the residents of Brooklyn for the quality of care he has provided for three decades," says Benjamin G. Neel, MD, PhD, director of NYU Langone's Perlmutter Cancer Center. "As a comprehensive cancer center serving New York City, we want to provide Brooklyn residents the very best, most convenient care. We are excited to have his leadership as we expand outreach in the borough."

NYU Langone's Perlmutter Cancer Center recently received designation from the National Cancer Institute (NCI), the highest-ranking a cancer program can achieve, for providing state-of-the-art, research-based approaches to preventing, detecting, and treating cancer.

Media Contacts: Ryan Dziuba
[email protected]
Phone: 212-404-4131
Mobile: 646-581-8548

This news release was issued on behalf of Newswisetm. For more information, visit http://www.newswise.com.

SOURCE NYU Langone Health


These press releases may also interest you

at 13:22
Houston, we don't have a foot care problem ? now that Modern Foot & Ankle has moved into the Lone Star State. The podiatric group originated in Florida and has a strong presence in Tampa, Orlando, and Palm Beach. But with its recent acquisition of a...

at 13:05
Gestalt Diagnostics has added healthcare industry expert, Dr. J. Mark Tuthill, to serve on Gestalt's Advisory Board. He will be joining Gestalt's distinguished Advisory Board of pathologists contributing to oversight and active input of development...

at 12:45
Leading research and experience management firm Sogolytics has released an original study examining the telehealth landscape, highlighting its achievements and challenges in providing positive experiences for patients. "It's critical for providers...

at 12:24
West Physics Consulting, LLC ("West Physics"), the leading national provider of integrated medical and health physics services, announced today that it has completed the purchase of the medical physics service division of Tricord, Inc. ("Tricord"), a...

at 12:16
Amae Health, a trailblazer in delivering patient-centered care for people with severe mental illness, announced today the successful closing of its oversubscribed $15 million Series A funding round. The round was led by Quiet Capital and included...

at 12:08
Roivios, a pioneering clinical-stage medical device company dedicated to transforming kidney health, is thrilled to announce it has been awarded the prestigious Breakthrough Device Designation by the U.S. Food and Drug Administration (FDA) for its...



News published on and distributed by: